Skip to main content
Start of main content.

Centre for Urology Research (CUR)

Our mission

The mission of the Centre for Urology Research is to enhance our knowledge of the lower urinary tract with the aim of developing new treatments or enhancing current treatments of the following conditions:

  • Interstitial cystitis
  • Stress and bladder & bowel dysfunction
  • Overactive bladder
  • Bladder and prostate cancer
  • Ureteral & kidney stones
  • Stress incontinence
  • Benign prostatic hyperplasia (enlarged prostate)
  • Erectile dysfunction

About the Centre for Urology Research (CUR)

Academic

Research interest

Professor Russ Chess-Williams Drug development for overactive bladder, stress incontinence, benign prostatic hyperplasia, erectile dysfunction and prostate bladder carcinoma
Associate Professor Catherine McDermott  Actions of cytotoxic drugs and their metabolites on bladder function
Associate Professor Donna Sellers Overactive bladder and diabetes, stress incontinence, bladder pathophysiology
Assistant Professor Anna Lohning Molecular modelling of uroplakins, drugs to treat prostate cancer
Associate Professor Christian Moro Overactive bladder and bladder physiology
Assistant Professor Stephanie SchweikerDevelopment of selective ARTD8 inhibitors for further understanding of androgen independent prostate cancers
Assistant Professor Stephan LevonisEffects of sialyltransferase inhibitors on bladder cell sialylation for malignancy
Assistant Professor Iris LimKidney stones and ureter physiology and pharmacology
Professor Gordon Wright Lower urinary tract pathology particularly urothelial carcinoma
Associate Professor Lotti TajouriMolecular genetics

Research Students

  • Aidan McKeonThe Effects of Diabetes on the Bladder. 
    Caitlin WunschDesign and Synthesis of Selective Poly (ADP-ribose) polymerase family member 14 (PARP14) inhibitors to potentially inhibit glucose metabolism in cancerous cells. 
    Charlotte PhelpsInteractions of receptor systems and second messengers in urinary bladder contractions. 
    Damian NilssonThe role of the vasculature in bladder function and dysfunction.The role of the vasculature in bladder function and dysfunction. 
    Hyo Jeong (Minnie) KimDesign, Synthesis and Evaluation of Sialyltransferase Inhibitors. 
    Jessica SmithEffects of psychological stress on bladder function. 
    Liam O’CallaghanQuinazoline-based cytotoxic drugs as intravesical treatments for bladder cancer. 
    Neil Josen Vinulan Delos Reyes Synthesis and Evaluation of a Novel Rhodamine Dye for Bioimaging with Gold Nanoparticles. 
    Vineesha VeerAlternative mechanisms of action for clinical antimuscarinics. 
  • 2022Amanda TauberDesign, Synthesis and Evaluation of Selective ADP-Ribosyltransferase Member 8 (ARTD8) Inhibitors.
    2022Caleb KamDesign, Synthesis, and Application of Selective Inhibitors for Poly (ADP-ribose) polymerase Members 1 and 14.
    2022Eleanor WestThe effects of inflammation on the afferent and efferent nerve responses of the bladder.
    2022Andy KohAn Investigation into the Authenticity of Citrus aurantium-Listing Pre-workout Supplements and Functional Evaluations of Their Trace Amines on the Vasculature.
    2021Zane StrombergaThe role of the inflammatory mediators in modulating bladder contractile activity.
    2021Eliza WestPsychological Stress and Bladder Dysfunction.
    2020Mei KhuthirAmitriptyline: Effects on Normal Bladder Function.
    2018Katrina Smith The impact of intravesical treatments for bladder pain syndrome on normal bladder function.
    2017Iris Lim  Mechanisms controlling ureteral motility.
    2017Oladayo Folasire Drug targets for urinary and faecal incontinence and anal fissures.
    2016Amanda Forbes Quinazoline-based Alpha 1 - Adrenoceptor antagonists and prostate cancer.
    2015Kylie Mills Cyclophosphamide and ifosfamide: Mechanisms of cytotoxic action and consequences for normal bladder function.
    2015Sung (Stanley) KangCytotoxic drugs and their effects on bladder function.
    2015Stefanie FarrIntravesical gemcitabine treatment:  Repercussions on  normal bladder function.
    2014Luke GrundyNon-neuronal ATP: Regulation of release and action in the bladder.
  • Charlotte Phelps 
    • Bond University 3-Minute Thesis Competition, August 2022 – winner
    Amanda Tauber
    • Bond University 3-Minute Thesis Competition, August 2019 - winner
    • FameLab national finals, May 2019 – finalist 
    • FameLab Queensland semi-final, March 2018 – runner-up
    Zane Stromberga
    • FameLab national finals, May 2018 – finalist 
    • FameLab Queensland semi-final, March 2018 - winner
    Eleanor West
    • 3-minute Presentation at 9th National Symposium on Advances in Gastrointestinal & Urogenital Research, December 2017 – winner
    Andy Koh
    • Poster Presentation at 9th National Symposium on Advances in Gastrointestinal & Urogenital Research, December 2017 – winner
    Iris Lim
    • Digital Poster Presentation at Gold Coast Health and Medical Research Conference, December 2015 – winner
    Oladayo Folasire
    • 3-minute Presentation at 6th National Symposium on Advances in Gastrointestinal & Urogenital Research, December 2014 – winner
    • Bond University 3-Minute Thesis Competition, August 2013 – winner
Aidan McKeonThe Effects of Diabetes on the Bladder. 
Caitlin WunschDesign and Synthesis of Selective Poly (ADP-ribose) polymerase family member 14 (PARP14) inhibitors to potentially inhibit glucose metabolism in cancerous cells. 
Charlotte PhelpsInteractions of receptor systems and second messengers in urinary bladder contractions. 
Damian NilssonThe role of the vasculature in bladder function and dysfunction.The role of the vasculature in bladder function and dysfunction. 
Hyo Jeong (Minnie) KimDesign, Synthesis and Evaluation of Sialyltransferase Inhibitors. 
Jessica SmithEffects of psychological stress on bladder function. 
Liam O’CallaghanQuinazoline-based cytotoxic drugs as intravesical treatments for bladder cancer. 
Neil Josen Vinulan Delos Reyes Synthesis and Evaluation of a Novel Rhodamine Dye for Bioimaging with Gold Nanoparticles. 
Vineesha VeerAlternative mechanisms of action for clinical antimuscarinics.